文献速递免疫规划妇幼与学校卫生

孕期接种Tdap后婴儿百日咳特异性抗体的动力学

Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.
PubMed 文献 · Vaccine · 2020-07-21

该研究纳入34对母婴,于2014年6月至2015年3月采集母亲接种Tdap前、接种后4周、分娩时及婴儿3、6周龄血样,定量检测百日咳特异性IgG。结果显示婴儿抗体半衰期约29-36天,短于既往报告,PT抗体≥10 IU/ml的婴儿比例从出生时97%降至6周龄67%。

要点

  • 孕期Tdap接种后婴儿百日咳抗体半衰期约29-36天,短于既往报告。
  • 婴儿PT特异性IgG从出生55.1 IU/mL降至6周龄21.1 IU/ml。
  • PT抗体≥10 IU/ml的婴儿比例从出生97%降至6周龄67%。

核心结论

  • 孕期Tdap接种诱导的婴儿百日咳特异性抗体半衰期为29-36天,短于既往报告。
  • 需理解被动获得抗体持久性对婴儿百日咳易感性和初次接种反应的影响以优化预防策略。

研究设计与样本

  • 前瞻性队列研究,纳入34对母婴,2014年6月至2015年3月采集母亲接种Tdap前、接种后4周、分娩时及婴儿3、6周龄血样。
  • 采用多重Luminex法检测百日咳毒素(PT)、丝状血凝素(FHA)、菌毛蛋白(FIM)和百日咳杆菌粘附素(PRN)的IgG(IU/ml)。

主要发现

  • 34名女性平均年龄31.1岁,接种Tdap时平均孕周30.7周(28-32.7);新生儿平均孕周39.1周(36-41.1),平均出生体重3379 g(2580-4584)。
  • 接种后4周,PT、FHA、FIM和PRN特异性IgG几何平均浓度(GMC)增长≥4倍者分别占59%、41%、29%和44%,随后下降。
  • 百日咳抗体经胎盘转运比率为PT 1.35、FHA 1.41、FIM 1.31、PRN 1.36。
  • 出生至6周龄,婴儿血清PT特异性IgG GMC从55.1 IU/mL(38.6-78.6)降至21.1 IU/ml(14.7-30.2),PT水平≥10 IU/ml的婴儿比例从97%降至67%。
  • 婴儿百日咳特异性IgG半衰期(天):PT 29.4(95% CI 27.3-31.7)、FHA 29.8(95% CI 27.7-32.2)、PRN 31.2(95% CI 28.9-33.7)、FIM 35.8(95% CI 30.1-44.3)。

临床怎么用

  • 孕期Tdap接种可提高母体抗体并经胎盘转运,但婴儿抗体衰减较快。
  • 需关注婴儿6周龄时PT抗体水平下降及≥10 IU/ml比例降低对易感性的影响。

局限性

  • 样本量较小(34对母婴)。
  • 未评估抗体持久性对婴儿百日咳发病及初次接种免疫应答的实际影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kinetics of Tdap-induced maternally-derived antibodies in infants are poorly understood. Pre-Tdap era data suggest that maternal pertussis antibodies in infants have a half-life of approximately 5-6 weeks. METHODS: 34 mother-infant pairs had blood collected before maternal Tdap vaccination, 4 weeks later, at delivery (maternal and cord), and at infant ages 3 and 6 weeks from June 2014-March 2015. Immunoglobulin G (IgG) to pertussis toxin (PT), filamentous hemagglutinin (FHA), fimbrial proteins (FIM) and pertactin (PRN) was quantified by multiplex luminex assay (IU/ml). Geometric mean concentrations (GMCs) with 95% confidence intervals (C.I.) and half-life of pertussis antibodies were calculated. RESULTS: Tdap was administered to 34 women (mean age 31.1 years) at mean gestation 30.7 weeks (28-32.7). Mean neonatal gestation was 39.1 weeks (36-41.1) and mean birthweight was 3379 g (2580-4584). Four weeks post-Tdap vaccination, maternal pertussis-specific IgG GMCs increased ≥4-fold in 59%, 41%, 29% and 44% of women for PT, FHA, FIM and PRN, respectively, and then waned. The transplacental transport ratio of pertussis antibodies was 1.35 for PT, 1.41 for FHA, 1.31 for FIM and 1.36 for PRN. Between birth and age 6 weeks, infant serum GMC for PT-specific IgG decreased from 55.1 IU/mL (38.6-78.6) to 21.1 IU/ml (14.7-30.2), and the proportion of infants with PT levels ≥10 IU/ml fell from 97% to 67%. Half-life of pertussis-specific IgG in infants in days was 29.4 (95% CI 27.3-31.7) for PT, 29.8 (95% CI 27.7-32.2) for FHA, 31.2 (95% CI 28.9-33.7) for PRN, and 35.8 (95% CI 30.1-44.3) for FIM. CONCLUSION: The half-life of pertussis-specific antibodies in infants induced by maternal Tdap vaccination (29-36 days) is shorter than previously reported. Understanding how the durability of passively-acquired antibodies impacts infant susceptibility to pertussis and response to primary vaccination is critical to refine prevention strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Healy CM, Rench MA, Swaim LS, et al. Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy. Vaccine. 2020. PMID: 32709433. doi:10.1016/j.vaccine.2020.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。